LK 01
Alternative Names: LK-001; LK-01; LK-SC001; UC-MSC - LiveKidney.Bio; Umbilical Cord–derived Mesenchymal Stromal Cells - LiveKidney.BioLatest Information Update: 14 Oct 2025
At a glance
- Originator LiveKidney.Bio
- Class Antirheumatics; Mesenchymal stem cell therapies; Skin disorder therapies; Urologics
- Mechanism of Action Cell replacements
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Systemic lupus erythematosus
- Clinical Phase Unknown IgA nephropathy; Kidney disorders; Lupus nephritis; Rheumatoid arthritis; Systemic scleroderma
Most Recent Events
- 14 Oct 2025 Clinical trials in IgA nephropathy (SC) prior to October 2025 (LiveKidney.Bio pipeline, October 2025)
- 14 Oct 2025 Clinical trials in Rheumatoid arthritis (SC) prior to October 2025 (LiveKidney.Bio pipeline, October 2025)
- 14 Oct 2025 Clinical trials in Systemic scleroderma (SC) (LiveKidney.Bio pipeline, October 2025)